GSK319347A
Product Specifications
UNSPSC Description
GSK319347A is a dual inhibitor of TBK1 and IKKε with IC50s of 93 nM and 469 nM, respectively. GSK319347A also inhibits IKK2 with an IC50 of 790 nM.
Target Antigen
IKK
Type
Reference compound
Related Pathways
NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ikk-3-inhibitor.html
Solubility
DMSO : 45 mg/mL (ultrasonic)
Smiles
COC1=CC2=C(C=C1OC)N(C3=CC(OCC4=CC=CC=C4S(=O)(C)=O)=C(C#N)S3)C=N2
Molecular Weight
469.53
References & Citations
[1]Johannes JW, et al. Discovery of 6-aryl-azabenzimidazoles that inhibit the TBK1/IKK-ε kinases. Bioorg Med Chem Lett. 2014 Feb 15;24(4):1138-43.|[2]Xie HZ, et al. Pharmacophore modeling and hybrid virtual screening for the discovery of novel IκB kinase 2 (IKK2) inhibitors. J Biomol Struct Dyn. 2011 Aug;29(1):165-79.
Shipping Conditions
Blue Ice
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-14682/GSK319347A-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-14682/GSK319347A-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
862812-98-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E07R0414-01 48 Well
Porcine RecQ mediated genome instability protein 1 (RMI1) ELISA Kit
Ask
View Details 
E07R0414-02 96 Well
Porcine RecQ mediated genome instability protein 1 (RMI1) ELISA Kit
Ask
View Details 
ARP35266_P050-FITC 100 µL
CHRNA9 Antibody - N-terminal region: FITC (ARP35266_P050-FITC)
Ask
View Details MBS1048054-01 0.02 mg (E-Coli)
Recombinant Rickettsia canadensis UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)
Ask
View Details